Trials / Conditions / Hospital Acquired Pneumonia (HAP)
Hospital Acquired Pneumonia (HAP)
6 registered clinical trials studyying Hospital Acquired Pneumonia (HAP) — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Real-World Effectiveness of Aztreonam-Avibactam Against MBL-Producing CRE NCT07268560 | Sir Run Run Shaw Hospital | — |
| Recruiting | Long-term Alterations of Host-microbiome Interactions and Cardiovascular and Respiratory Diseases Progression NCT06602934 | Nantes University Hospital | N/A |
| Completed | A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of Cefiderocol i NCT04335539 | Shionogi | Phase 2 |
| Completed | Ceftobiprole in the Treatment of Pediatric Patients With Pneumonia NCT03439124 | Basilea Pharmaceutica | Phase 3 |
| Completed | Clinical Study of Cefiderocol (S-649266) for the Treatment of Nosocomial Pneumonia Caused by Gram-negative Pat NCT03032380 | Shionogi | Phase 3 |
| Completed | Study of Cefiderocol (S-649266) or Best Available Therapy for the Treatment of Severe Infections Caused by Car NCT02714595 | Shionogi | Phase 3 |